Atea Pharmaceuticals Inc (AVIR)
3.385
+0.08
(+2.27%)
USD |
NASDAQ |
Jul 01, 16:00
3.385
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Enterprise Value: -262.71M for June 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 28, 2024 | -262.71M |
| June 27, 2024 | -256.82M |
| June 26, 2024 | -257.66M |
| June 25, 2024 | -252.61M |
| June 24, 2024 | -247.55M |
| June 21, 2024 | -251.76M |
| June 20, 2024 | -253.45M |
| June 18, 2024 | -247.55M |
| June 17, 2024 | -244.18M |
| June 14, 2024 | -237.45M |
| June 13, 2024 | -229.87M |
| June 12, 2024 | -223.13M |
| June 11, 2024 | -211.34M |
| June 10, 2024 | -222.29M |
| June 07, 2024 | -229.87M |
| June 06, 2024 | -221.44M |
| June 05, 2024 | -207.97M |
| June 04, 2024 | -223.97M |
| June 03, 2024 | -213.86M |
| May 31, 2024 | -232.39M |
| May 30, 2024 | -237.45M |
| May 29, 2024 | -244.18M |
| May 28, 2024 | -237.45M |
| May 24, 2024 | -233.23M |
| May 23, 2024 | -230.71M |
| Date | Value |
|---|---|
| May 22, 2024 | -219.76M |
| May 21, 2024 | -237.45M |
| May 20, 2024 | -238.29M |
| May 17, 2024 | -234.08M |
| May 16, 2024 | -229.87M |
| May 15, 2024 | -229.02M |
| May 14, 2024 | -207.97M |
| May 13, 2024 | -201.23M |
| May 10, 2024 | -213.86M |
| May 09, 2024 | -210.49M |
| May 08, 2024 | -210.49M |
| May 07, 2024 | -209.65M |
| May 06, 2024 | -204.60M |
| May 03, 2024 | -207.97M |
| May 02, 2024 | -218.92M |
| May 01, 2024 | -217.23M |
| April 30, 2024 | -229.87M |
| April 29, 2024 | -229.02M |
| April 26, 2024 | -229.02M |
| April 25, 2024 | -230.71M |
| April 24, 2024 | -229.87M |
| April 23, 2024 | -227.34M |
| April 22, 2024 | -232.39M |
| April 19, 2024 | -228.18M |
| April 18, 2024 | -229.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-396.68M
Minimum
Mar 24 2023
6.441B
Maximum
Feb 08 2021
517.44M
Average
-203.57M
Median
Enterprise Value Benchmarks
| Cytokinetics Inc | 5.683B |
| Insmed Inc | 11.50B |
| PetMed Express Inc | 28.99M |
| Sana Biotechnology Inc | 898.32M |
| Prime Medicine Inc | 406.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -63.17M |
| Total Expenses (Quarterly) | 69.81M |
| EPS Diluted (Quarterly) | -0.75 |
| Earnings Yield | -57.90% |
| Operating Earnings Yield | 48.93% |
| Normalized Earnings Yield | 40.18 |